← FDA DRUG APPROVALS

FDA ANDA · ANDA087510

PROCAN SR

Sponsor: PARKEDALE

APPLICATION
ANDA087510
TYPE
ANDA
ORIGINAL APPROVAL
1995-09-22
LATEST ACTION
1996-05-30
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PROCAN SR · ReferenceDiscontinued
PROCAINAMIDE HYDROCHLORIDE 750MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

1996-05-30Labeling · Supplement 29AP
1995-09-22OriginalAP
1993-06-23Labeling · Supplement 26AP
1992-03-03Labeling · Supplement 25AP
1991-06-06Labeling · Supplement 24AP
1989-01-27Labeling · Supplement 20AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →